Psychological stress and the cutaneous immune response: Roles of the HPA Axis and the sympathetic nervous system in atopic dermatitis and psoriasis

Dermatology Research and Practice

Volumn 2012, Issue , 2012, Pages

  Hall, Jessica M F ^a   Cruser, Desanges ^b   Podawiltz, Alan ^b   Mummert, Diana I ^b   Jones, Harlan ^a   Mummert, Mark E ^b,c  

^a UNIVERSITY OF NORTH TEXAS   (United States)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CORTICOTROPIN; INTERLEUKIN 6; ISOTRETINOIN; NERVE GROWTH FACTOR; NORADRENALIN;

ADAPTIVE IMMUNITY; ADRENERGIC SYSTEM; ANTIGEN PRESENTATION; ATOPIC DERMATITIS; CHRONIC STRESS; CHRONICITY; CYTOKINE PRODUCTION; DISEASE SEVERITY; HYPNOSIS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; IMMUNOMODULATION; INNATE IMMUNITY; LANGERHANS CELL; MAST CELL DEGRANULATION; MENTAL STRESS; NONHUMAN; PROTEIN EXPRESSION; PSORIASIS; REVIEW; STRATUM CORNEUM;

EID: 84867005195     PISSN: None     EISSN: 16876113     Source Type: Journal    
DOI: 10.1155/2012/403908     Document Type: Review

References (114)

1. Dhabhar F. S., Miller A. H., Stein M., McEwen B. S., Spencer R. L., Diurnal and acute stress-induced changes in distribution of peripheral blood leukocyte subpopulations. Brain, Behavior, and Immunity 1994 8 1 66 79 2-s2.0-0028356324 10.1006/brbi.1994.1006
2. Dhabhar F. S., Miller A. H., McEwen B. S., Spencer R. L., Effects of stress on immune cell distribution: dynamics and hormonal mechanisms. Journal of Immunology 1995 154 10 5511 5527 2-s2.0-0029011165
3. Dhabhar F. S., McEwen B. S., Acute stress enhances while chronic stress suppresses cell-mediated immunity in vivo: a potential role for leukocyte trafficking. Brain, Behavior, and Immunity 1997 11 4 286 306 2-s2.0-0031415757 10.1006/brbi.1997.0508
4. Dhabhar F. S., Mcewen B. S., Enhancing versus suppressive effects of stress hormones on skin immune function. Proceedings of the National Academy of Sciences of the United States of America 1999 96 3 1059 1064 2-s2.0-0033514465 10.1073/pnas.96.3.1059
5. Dhabhar F. S., Acute stress enhances while chronic stress suppresses skin immunity: the role of stress hormones and leukocyte trafficking. Annals of the New York Academy of Sciences 2000 917 876 893 2-s2.0-0033665450
6. Altemus M., Rao B., Dhabhar F. S., Ding W., Granstein R. D., Stress-induced changes in skin barrier function in healthy women. Journal of Investigative Dermatology 2001 117 2 309 317 2-s2.0-0035722018 10.1046/j.1523-1747.2001.01373.x
7. Bowers S. L., Bilbo S. D., Dhabhar F. S., Nelson R. J., Stressor-specific alterations in corticosterone and immune responses in mice. Brain, Behavior, and Immunity 2008 22 1 105 113 2-s2.0-36749094497 10.1016/j.bbi.2007.07.012
8. Cannon W. B., The emergency function of the adrenal medulla in pain and the major emotions. American Journal of Physiology 1914 33 2 356 372
9. Jafferany M., Psychodermatology: a guide to understanding common psychocutaneous disorders. Primary Care Companion to the Journal of Clinical Psychiatry 2007 9 3 203 213 2-s2.0-34249934155
10. Aktan S., Özmen E., Şanli B., Psychiatric disorders in patients attending a dermatology outpatient clinic. Dermatology 1998 197 3 230 234 2-s2.0-0031663024 10.1159/000018002
11. Picardi A., Abeni D., Melchi C. F., Puddu P., Pasquini P., Psychiatric morbidity in dermatological outpatients: an issue to be recognized. British Journal of Dermatology 2000 143 5 983 991 2-s2.0-0033730336 10.1046/j.1365-2133. 2000.03831.x
12. Shenefelt P. D., Psychodermatological disorders: recognition and treatment. International Journal of Dermatology 2011 50 11 1309 1322
13. Tsagarakis S., Navara P., Rees L. H., Besser M., Grossman A., Morphine directly modulates the release of stimulated corticotrophin-releasing factor-41 from rat hypothalamus in vitro. Endocrinology 1989 124 5 2330 2335 2-s2.0-0024523570
14. Calogero A. E., Bernardini R., Margioris A. N., Bagdy G., Gallucci W. T., Munson P. J., Tamarkin L., Tomai T. P., Brady L., Gold P. W., Chrousos G. P., Effects of serotonergic agonists and antagonists on corticotropin-releasing hormone secretion by explanted rat hypothalami. Peptides 1989 10 1 189 200 2-s2.0-0024551322
15. Wei R., Phillips T. M., Sternberg E. M., Specific up-regulation of CRH or AVP secretion by acetylcholine or lipopolysaccharide in inflammatory susceptible Lewis rat fetal hypothalamic cells. Journal of Neuroimmunology 2002 131 1-2 31 40 2-s2.0-0036789973 10.1016/S0165-5728(02)00251-5
16. Raber J., Sorg O., Horn T. F. W., Yu N., Koob G. F., Campbell I. L., Bloom F. E., Inflammatory cytokines: putative regulators of neuronal and neuro- endocrine function. Brain Research Reviews 1998 26 2-3 320 326 2-s2.0-0032078509 10.1016/S0165-0173(97)00041-6
17. Kariagina A., Romanenko D., Ren S. G., Chesnokova V., Hypothalamic-pituitary cytokine network. Endocrinology 2004 145 1 104 112 2-s2.0-0345827725 10.1210/en.2003-0669
18. Elenkov I. J., Wilder R. L., Chrousos G. P., Vizi E. S., The sympathetic nervean integrative interface between two supersystems: the brain and the immune system. Pharmacological Reviews 2000 52 4 595 638 2-s2.0-0033638849
19. Bernardini R., Chiarenza A., Kamilaris T. C., Renaud N., Lempereur L., Demitrack M., Gold P. W., Chrousos G. P., In vivo and in vitro effects of arginine-vasopressin receptor antagonists on the hypothalamic-pituitary-adrenal axis in the rat. Neuroendocrinology 1994 60 5 503 508 2-s2.0-0028061346
20. Whitnall M. H., Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system. Progress in Neurobiology 1993 40 5 573 629 2-s2.0-0027460680
21. Tausk F., Elenkov I., Moynihan J., Psychoneuroimmunology. Dermatologic Therapy 2008 21 1 22 31 2-s2.0-40349085941 10.1111/j.1529-8019.2008.00166.x
22. Tsigos C., Chrousos G. P., Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. Journal of Psychosomatic Research 2002 53 4 865 871 2-s2.0-0036805791 10.1016/S0022-3999(02)00429-4
23. Miyazaki Y., Yokozeki H., Awad S., Igawa K., Minatohara K., Satoh T., Katayama I., Nishioka K., Glucocorticoids augment the chemically induced production and gene expression of interleukin-1 α through NF- κ B and AP-1 activation in murine epidermal cells. Journal of Investigative Dermatology 2000 115 4 746 752 2-s2.0-0033770033 10.1046/j.1523-1747.2000.00101. x
24. Zimmerman B. G., Whitmore L., Transmitter release in skin and muscle blood vessels during sympathetic stimulation. The American Journal of Physiology 1967 212 5 1043 1054 2-s2.0-0014088731
25. Pergola P. E., Kellogg D. L. Jr., Johnson J. M., Kosiba W. A., Solomon D. E., Role of sympathetic nerves in the vascular effects of local temperature in human forearm skin. American Journal of Physiology 1993 265 3 H785 H792 2-s2.0-0027449315
26. Kellogg D. L. Jr., In vivo mechanisms of cutaneous vasodilation and vasoconstriction in humans during thermoregulatory challenges. Journal of Applied Physiology 2006 100 5 1709 1718 2-s2.0-33746876004 10.1152/japplphysiol. 01071.2005
27. Kvetnansky R., Sabban E. L., Palkovits M., Catecholaminergic systems in stress: structural and molecular genetic approaches. Physiological Reviews 2009 89 2 535 606 2-s2.0-67649995436 10.1152/physrev.00042.2006
28. Sephton S. E., Dhabhar F. S., Keuroghlian A. S., Giese-Davis J., McEwen B. S., Ionan A. C., Spiegel D., Depression, cortisol, and suppressed cell-mediated immunity in metastatic breast cancer. Brain, Behavior, and Immunity 2009 23 8 1148 1155 2-s2.0-73049092762 10.1016/j.bbi.2009.07.007
29. Joachim R. A., Kuhlmei A., Dinh Q. T., Handjiski B., Fischer T., Peters E. M. J., Klapp B. F., Paus R., Arck P. C., Neuronal plasticity of the brain-skin connection: stress-triggered up-regulation of neuropeptides in dorsal root ganglia and skin via nerve growth factor-dependent pathways. Journal of Molecular Medicine 2007 85 12 1369 1378 2-s2.0-36849006908 10.1007/s00109-007- 0236-8
30. Levi-Montalcini R., Skaper S. D., Dal Toso R., Petrelli L., Leon A., Nerve growth factor: from neurotrophin to neurokine. Trends in Neurosciences 1996 19 11 514 520 2-s2.0-0030296428 10.1016/S0166-2236(96)10058-8
31. Peters E. M. J., Botchkarev V. A., Botchkareva N. V., Tobin D. J., Paus R., Hair-cycle-associated remodeling of the peptidergic innervation of murine skin, and hair growth modulation by neuropeptides. Journal of Investigative Dermatology 2001 116 2 236 245 2-s2.0-0035112675 10.1046/j.1523-1747.2001.01232. x
32. Asadi S., Alysandratos K. D., Angelidou A., Miniati A., Sismanopoulos N., Vasiadi M., Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells. Journal of Investigative Dermatology 2012 132 2 324 329
33. Hosoi J., Murphy G. F., Egan C. L., Lerner E. A., Grabbe S., Asahina A., Granstein R. D., Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 1993 363 6425 159 163 2-s2.0-0027314249 10.1038/363159a0
34. Staniek V., Misery L., Péguet-Navarro J., Abello J., Doutremepuich J. D., Claudy A., Schmitt D., Binding and in vitro modulation of human epidermal Langerhans cell functions by substance P. Archives of Dermatological Research 1997 289 5 285 291 2-s2.0-0030836380 10.1007/s004030050194
35. Slominski A., Pisarchik A., Tobin D. J., Mazurkiewicz J. E., Wortsman J., Differential expression of a cutaneous corticotropin-releasing hormone system. Endocrinology 2004 145 2 941 950 2-s2.0-0842291543 10.1210/en.2003-0851
36. Slominski A., Wortsman J., Pisarchik A., Zbytek B., Linton E. A., Mazurkiewicz J. E., Wei E. T., Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB Journal 2001 15 10 1678 1693 2-s2.0-0034901194 10.1096/fj.00-0850rev
37. Slominski A., Roloff B., Curry J., Dahiya M., Szczesniewski A., Wortsman J., The skin produces urocortin. Journal of Clinical Endocrinology and Metabolism 2000 85 2 815 823 2-s2.0-0034453102 10.1210/jc.85.2.815
38. Hsu S. Y., Hsueh A. J. W., Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nature Medicine 2001 7 5 605 611 2-s2.0-0000432665 10.1038/87936
39. Grammatopoulos D. K., Chrousos G. P., Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists. Trends in Endocrinology and Metabolism 2002 13 10 436 444 2-s2.0-0038407615 10.1016/S1043-2760(02)00670-7
40. Slominski A., Szczesniewski A., Wortsman J., Liquid chromatography-mass spectrometry detection of corticotropin-releasing hormone and proopiomelanocortin-derived peptides in human skin. Journal of Clinical Endocrinology and Metabolism 2000 85 10 3582 3588 2-s2.0-0033756505
41. Kono M., Nagata H., Umemura S., Kawana S., Osamura R. Y., In situ expression of corticotropin-releasing hormone (CRH) and proopiomelanocortin (POMC) genes in human skin. The FASEB Journal 2001 15 12 2297 2299 2-s2.0-0035487506
42. Ito N., Ito T., Kromminga A., Bettermann A., Takigawa M., Kees F., Straub R. H., Paus R., Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal axis and synthesize cortisol. FASEB Journal 2005 19 10 1332 1334 2-s2.0-23444462244 10.1096/fj.04-1968fje
43. Foitzik K., Krause K., Nixon A. J., Ford C. A., Ohnemus U., Pearson A. J., Paus R., Prolactin and its receptor are expressed in murine hair follicle epithelium, show hair cycle-dependent expression, and induce catagen. American Journal of Pathology 2003 162 5 1611 1621 2-s2.0-0037408394
44. Langan E. A., Foitzik-Lau K., Goffin V., Ramot Y., Paus R., Prolactin: an emerging force along the cutaneous-endocrine axis. Trends in Endocrinology and Metabolism 2010 21 9 569 577 2-s2.0-77956185193 10.1016/j.tem.2010.06.001
45. Ramot Y., Bíró T., Tiede S., Tóth B. I., Langan E. A., Sugawara K., Foitzik K., Ingber A., Goffin V., Langbein L., Paus R., Prolactina novel neuroendocrine regulator of human keratin expression in situ. FASEB Journal 2010 24 6 1768 1779 2-s2.0-77953489794 10.1096/fj.09-146415
46. Slominski A., Tobin D. J., Zmijewski M. A., Wortsman J., Paus R., Melatonin in the skin: synthesis, metabolism and functions. Trends in Endocrinology and Metabolism 2008 19 1 17 24 2-s2.0-40749099426 10.1016/j.tem.2007.10.007
47. Weihe E., Schütz B., Hartschuh W., Anlauf M., Schäfer M. K., Eiden L. E., Coexpression of cholinergic and noradrenergic phenotypes in human and nonhuman autonomic nervous system. Journal of Comparative Neurology 2005 492 3 370 379 2-s2.0-27544457655 10.1002/cne.20745
48. Schütz B., von Engelhardt J., Gördes M., Schäfer M. K. H., Eiden L. E., Monyer H., Weihe E., Sweat gland innervation is pioneered by sympathetic neurons expressing a cholinergic/noradrenergic co-phenotype in the mouse. Neuroscience 2008 156 2 310 318 2-s2.0-52949114548 10.1016/j. neuroscience.2008.06.074
49. Marks R., The stratum corneum barrier: the final frontier. Journal of Nutrition 2004 134 8, aupplement 2017S 2021S 2-s2.0-3543133671
50. Denda M., Tsuchiya T., Hosoi J., Koyama J., Immobilization-induced and crowded environment-induced stress delay barrier recovery in murine skin. British Journal of Dermatology 1998 138 5 780 785 2-s2.0-0031779722 10.1046/j.1365-2133.1998.02213.x
51. Garg A., Chren M. M., Sands L. P., Matsui M. S., Marenus K. D., Feingold K. R., Elias P. M., Psychological stress perturbs epidermal permeability barrier homeostasis: implications for the pathogenesis of stress-associated skin disorders. Archives of Dermatology 2001 137 1 53 59 2-s2.0-0035144999
52. Choi E. H., Brown B. E., Crumrine D., Chang S., Man M. Q., Elias P. M., Feingold K. R., Mechanisms by which psychologic stress alters cutaneous permeability barrier homeostasis and stratum corneum integrity. Journal of Investigative Dermatology 2005 124 3 587 595 2-s2.0-15044353754 10.1111/j.0022-202X.2005.23589.x
53. Choi E. H., Demerjian M., Crumrine D., Brown B. E., Mauro T., Elias P. M., Feingold K. R., Glucocorticoid blockade reverses psychological stress-induced abnormalities in epidermal structure and function. American Journal of Physiology 2006 291 6 R1657 R1662 2-s2.0-33845416886 10.1152/ajpregu.00010.2006
54. Aberg K. M., Radek K. A., Choi E. H., Kim D. K., Demerjian M., Hupe M., Kerbleski J., Gallo R. L., Ganz T., Mauro T., Feingold K. R., Elias P. M., Psychological stress downregulates epidermal antimicrobial peptide expression and increases severity of cutaneous infections in mice. Journal of Clinical Investigation 2007 117 11 3339 3349 2-s2.0-36048989909 10.1172/JCI31726
55. Graham H. T., Lowry O. H., Wahl N., Priebat M. K., Mast cells as sources of tissue histamine. The Journal of experimental medicine 1955 102 3 307 318 2-s2.0-0002614132
56. Cowen T., Trigg P., Eady R. A. J., Distribution of mast cells in human dermis: development of a mapping technique. British Journal of Dermatology 1979 100 6 635 640 2-s2.0-0018635226
57. Eady R. A. J., Cowen T., Marshall T. F., Mast cell population density, blood vessel density and histamine content in normal human skin. British Journal of Dermatology 1979 100 6 623 633 2-s2.0-0018581426
58. Cao J., Papadopoulou N., Kempuraj D., Boucher W. S., Sugimoto K., Cetrulo C. L., Theoharides T. C., Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor. Journal of Immunology 2005 174 12 7665 7675 2-s2.0-20444366589
59. Huang M., Berry J., Kandere K., Lytinas M., Karalis K., Theoharides T. C., Mast cell deficient W/WV mice lack stress-induced increase in serum IL-6 levels, as well as in peripheral CRH and vascular permeability, a model of rheumatoid arthritis. International Journal of Immunopathology and Pharmacology 2002 15 3 249 254 2-s2.0-0036753809
60. Banks W. A., Kastin A. J., Gutierrez E. G., Penetration of interleukin-6 across the murine blood-brain barrier. Neuroscience Letters 1994 179 1-2 53 56 2-s2.0-0028049995 10.1016/0304-3940(94)90933-4
61. Mastorakos G., Chrousos G. P., Weber J. S., Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. Journal of Clinical Endocrinology and Metabolism 1993 77 6 1690 1694 2-s2.0-0027131202 10.1210/jc.77.6.1690
62. Kitani A., Hara M., Hirose T., Harigai M., Suzuki K., Kawakami M., Kawaguchi Y., Hidaka T., Kawagoe M., Nakamura H., Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression. Clinical and Experimental Immunology 1992 88 1 75 83 2-s2.0-0026560191
63. Takeda K., Kaisho T., Yoshida N., Takeda J., Kishimoto T., Akira S., Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell- specific stat3-deficient mice. Journal of Immunology 1998 161 9 4652 4660 2-s2.0-0032213273
64. Dienz O., Eaton S. M., Bond J. P., Neveu W., Moquin D., Noubade R., Briso E. M., Charland C., Leonard W. J., Ciliberto G., Teuscher C., Haynes L., Rincon M., The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells. Journal of Experimental Medicine 2009 206 1 69 78 2-s2.0-60549105041 10.1084/jem.20081571
65. Kagiwada K., Chida D., Sakatani T., Asano M., Nambu A., Kakuta S., Iwakura Y., Interleukin (IL)-6, but not IL-1, induction in the brain downstream of cyclooxygenase-2 is essential for the induction of febrile response against peripheral IL-1 α Endocrinology 2004 145 11 5044 5048 2-s2.0-9244249142 10.1210/en.2004-0054
66. Castell J. V., Gomez-Lechon M. J., David M., Andus T., Geiger T., Trullenque R., Fabra R., Heinrich P. C., Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Letters 1989 242 2 237 239 2-s2.0-0024581491 10.1016/0014-5793(89)80476-4
67. Castell J. V., Andus T., Kunz D., Heinrich P. C., Interleukin-6: the major regulator of acute-phase protein synthesis in man and rat. Annals of the New York Academy of Sciences 1989 557 87 101 2-s2.0-0024323353
68. Singh L. K., Pang X., Alexacos N., Letourneau R., Theoharides T. C., Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin, and substance P: a link to neurogenic skin disorders. Brain, Behavior, and Immunity 1999 13 3 225 239 2-s2.0-0032856498 10.1006/brbi.1998.0541
69. Arck P. C., Handjiski B., Hagen E., Joachim R., Klapp B. F., Paus R., Indications for a brain-hair follicle axis (BHA): inhibition of keratinocyte proliferation and up-regulation of keratinocyte apoptosis in telogen hair follicles by stress and substance P. The FASEB Journal 2001 15 13 2536 2538 2-s2.0-0035514401
70. Pavlovic S., Daniltchenko M., Tobin D. J., Hagen E., Hunt S. P., Klapp B. F., Arck P. C., Peters E. M. J., Further exploring the brain-skin connection: stress worsens dermatitis via substance P-dependent neurogenic inflammation in mice. Journal of Investigative Dermatology 2008 128 2 434 446 2-s2.0-38149013922 10.1038/sj.jid.5701079
71. Shimoda T., Liang Z., Suzuki H., Kawana S., Inhibitory effects of antipsychotic and anxiolytic agents on stress-induced degranulation of mouse dermal mast cells: experimental dermatology. Clinical and Experimental Dermatology 2010 35 5 531 536 2-s2.0-77953332775 10.1111/j.1365-2230.2009.03650. x
72. Nakano Y., Effect of chronic topical exposure to low-dose noxious chemicals and stress on skin sensitivity in mice. Journal of Occupational Health 2007 49 6 431 442 2-s2.0-37549003230 10.1539/joh.49.431
73. Flint M. S., Miller D. B., Tinkle S. S., Restraint-induced modulation of allergic and irritant contact dermatitis in male and female B6.129 Mice. Brain, Behavior, and Immunity 2000 14 4 256 269 2-s2.0-0034527776 10.1006/brbi.2000. 0604
74. Flint M. S., Tinkle S. S., C57BL/6 mice are resistant to acute restraint modulation of cutaneous hypersensitivity. Toxicological Sciences 2001 62 2 250 256 2-s2.0-0034899099 10.1093/toxsci/62.2.250
75. Wistar R. Jr., Hildemann W. H., Effect of stress on skin transplantation immunity in mice. Science 1960 131 3394 159 160 2-s2.0-0006954154
76. Cremaschi G. A., Gorelik G., Klecha A. J., Lysionek A. E., Genaro A. M., Chronic stress influences the immune system through the thyroid axis. Life Sciences 2000 67 26 3171 3179 2-s2.0-0034680733
77. Bartrop R. W., Luckhurst E., Lazarus L., Depressed lymphocyte function after bereavement. Lancet 1977 1 8016 834 836 2-s2.0-0017345520
78. Hosoi J., Tsuchiya T., Denda M., Ashida Y., Takashima A., Granstein R. D., Koyama J., Modification of LC phenotype and suppression of contact hypersensitivity response by stress. Journal of Cutaneous Medicine and Surgery 1998 3 2 79 84 2-s2.0-0031792719
79. Kleyn C. E., Schneider L., Saraceno R., Mantovani C., Richards H. L., Fortune D. G., Cumberbatch M., Dearman R. J., Terenghi G., Kimber I., Griffiths C. E. M., The effects of acute social stress on epidermal Langerhans' cell frequency and expression of cutaneous neuropeptides. Journal of Investigative Dermatology 2008 128 5 1273 1279 2-s2.0-42149163393 10.1038/sj.jid.5701144
80. Clausen B. E., Kel J. M., Langerhans cells: critical regulators of skin immunity. Immunology and Cell Biology 2010 88 4 351 360 2-s2.0-77952220955 10.1038/icb.2010.40
81. Hoetzenecker W., Meingassner J. G., Ecker R., Stingl G., Stuetz A., Elbe-Bürger A., Corticosteroids but not pimecrolimus affect viability, maturation and immune function of murine epidermal langerhans cells. Journal of Investigative Dermatology 2004 122 3 673 684 2-s2.0-1842639441 10.1111/j.0022-202X.2004.22324.x
82. Seiffert K., Hosoi J., Torii H., Ozawa H., Ding W., Campton K., Wagner J. A., Granstein R. D., Catecholamines inhibit the antigen-presenting capability of epidermal langerhans cells. Journal of Immunology 2002 168 12 6128 6135 2-s2.0-0037097515
83. Elenkov I. J., Papanicolaou D. A., Wilder R. L., Chrousos G. P., Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proceedings of the Association of American Physicians 1996 108 5 374 381 2-s2.0-0030227883
84. Panina-Bordignon P., Mazzeo D., Di Lucia P., D'Ambrosio D., Lang R., Fabbri L., Self C., Sinigaglia F., β 2-agonists prevent Th1 development by selective inhibition of interleukin 12. Journal of Clinical Investigation 1997 100 6 1513 1519 2-s2.0-0030612187
85. Seiffert K., Granstein R. D., Neuroendocrine regulation of skin dendritic cells. Annals of the New York Academy of Sciences 2006 1088 195 206 2-s2.0-34447625541 10.1196/annals.1366.011
86. Yanagawa Y., Matsumoto M., Togashi H., Enhanced dendritic cell antigen uptake via α 2 adrenoceptor-mediated PI3K activation following brief exposure to noradrenaline. Journal of Immunology 2010 185 10 5762 5768 2-s2.0-78650671623 10.4049/jimmunol.1001899
87. Ding W., Stohl L. L., Wagner J. A., Granstein R. D., Calcitonin gene-related peptide biases langerhans cells toward Th2-type immunity. Journal of Immunology 2008 181 9 6020 6026 2-s2.0-58749108125
88. Hanifin J. M., Reed M. L., Drake L. A., Koo J., Lebwohl M. G., Leung D. Y. M., McAlister R. O., Pariser D. M., Weiss S. T., A population-based survey of eczema prevalence in the United States. Dermatitis 2007 18 2 82 91 2-s2.0-34547152817 10.2310/6620.2007.06034
89. Thepen T., Langeveld-Wildschut E. G., Bihari I. C., Van Wichen D. F., Van Reijsen F. C., Mudde G. C., Bruijnzeel-Koomen C. A. F. M., Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial T(H2) response to a T(H1) response in situ: an immunocytochemical study. Journal of Allergy and Clinical Immunology 1996 97 3 828 837 2-s2.0-0029981818 10.1016/S0091-6749(96)80161-8
90. Grewe M., Bruijnzeel-Koomen C. A. F. M., Schöpf E., Thepen T., Langeveld-Wildschut A. G., Ruzicka T., Krutmann J., A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunology Today 1998 19 8 359 361 2-s2.0-0031871705 10.1016/S0167-5699(98)01285-7
91. Hashizume H., Takigawa M., Anxiety in allergy and atopic dermatitis. Current Opinion in Allergy and Clinical Immunology 2006 6 5 335 339 2-s2.0-33748538338 10.1097/01.all.0000244793.03239.40
92. Kodama A., Horikawa T., Suzuki T., Ajiki W., Takashima T., Harada S., Ichihashi M., Effect of stress on atopic dermatitis: investigation in patients after the Great Hanshin Earthquake. Journal of Allergy and Clinical Immunology 1999 104 1 173 176 2-s2.0-0032867098 10.1016/S0091-6749(99)70130-2
93. Buske-Kirschbaum A., Gierens A., Höllig H., Hellhammer D. H., Stress-induced immunomodulation is altered in patients with atopic dermatitis. Journal of Neuroimmunology 2002 129 1-2 161 167 2-s2.0-0036341182 10.1016/S0165-5728(02)00168-6
94. Buske-Kirschbaum A., Geiben A., Höllig H., Morschhäuser E., Hellhammer D., Altered responsiveness of the hypothalamus-pituitary-adrenal axis and the sympathetic adrenomedullary system to stress in patients with atopic dermatitis. Journal of Clinical Endocrinology and Metabolism 2002 87 9 4245 4251 2-s2.0-0036738399 10.1210/jc.2001-010872
95. Toyoda M., Nakamura M., Makino T., Hino T., Kagoura M., Morohashi M., Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. British Journal of Dermatology 2002 147 1 71 79 2-s2.0-0036063881 10.1046/j.1365-2133.2002.04803.x
96. Wang I. J., Hsieh W. S., Guo Y. L., Jee S. H., Hsieh C. J., Hwang Y. H., Chen P. C., Neuro-mediators as predictors of paediatric atopic dermatitis. Clinical and Experimental Allergy 2008 38 8 1302 1308 2-s2.0-47649111710 10.1111/j.1365-2222.2008.03026.x
97. Lonne-Rahm S. B., Rickberg H., El-Nour H., Mårin P., Azmitia E. C., Nordlind K., Neuroimmune mechanisms in patients with atopic dermatitis during chronic stress. Journal of the European Academy of Dermatology and Venereology 2008 22 1 11 18 2-s2.0-37749040156 10.1111/j.1468-3083.2007.02202.x
98. Sander H. M., Morris L. F., Phillips C. M., Harrison P. E., Menter A., The annual cost of psoriasis. Journal of the American Academy of Dermatology 1993 28 3 422 425 2-s2.0-0027394088
99. Gelfand J. M., Gladman D. D., Mease P. J., Smith N., Margolis D. J., Nijsten T., Stern R. S., Feldman S. R., Rolstad T., Epidemiology of psoriatic arthritis in the population of the United States. Journal of the American Academy of Dermatology 2005 53 4 573 577 2-s2.0-25844490095 10.1016/j.jaad.2005. 03.046
100. Gelfand J. M., Weinstein R., Porter S. B., Neimann A. L., Berlin J. A., Margolis D. J., Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Archives of Dermatology 2005 141 12 1537 1541 2-s2.0-29144466801 10.1001/archderm.141.12.1537
101. Elder J. T., Bruce A. T., Gudjonsson J. E., Johnston A., Stuart P. E., Tejasvi T., Voorhees J. J., Abecasis G. R., Nair R. P., Molecular dissection of psoriasis: integrating genetics and biology. Journal of Investigative Dermatology 2010 130 5 1213 1226 2-s2.0-77951094127 10.1038/jid.2009.319
102. Kryczek I., Bruce A. T., Gudjonsson J. E., Johnston A., Aphale A., Vatan L., Szeliga W., Wang Y., Liu Y., Welling T. H., Elder J. T., Zou W., Induction of IL-17+ T cell trafficking and development by IFN- γ: mechanism and pathological relevance in psoriasis. Journal of Immunology 2008 181 7 4733 4741 2-s2.0-58149316658
103. Al'Abadie M. S., Kent G. G., Gawkrodger D. J., The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. British Journal of Dermatology 1994 130 2 199 203 2-s2.0-0028225496 10.1111/j.1365-2133.1994.tb02900.x
104. Griffiths C. E. M., Richards H. L., Psychological influences in psoriasis. Clinical and Experimental Dermatology 2001 26 4 338 342 2-s2.0-0035725075 10.1046/j.1365-2230.2001.00834.x
105. Buske-Kirschbaum A., Kern S., Ebrecht M., Hellhammer D. H., Altered distribution of leukocyte subsets and cytokine production in response to acute psychosocial stress in patients with psoriasis vulgaris. Brain, Behavior, and Immunity 2007 21 1 92 99 2-s2.0-33845187148 10.1016/j.bbi.2006.03.006
106. Schmid-Ott G., Jaeger B., Boehm T., Langer K., Stephan M., Raap U., Werfel T., Immunological effects of stress in psoriasis. British Journal of Dermatology 2009 160 4 782 785 2-s2.0-62649096225 10.1111/j.1365-2133.2008. 09013.x
107. Buske-Kirschbaum A., Ebrecht M., Kern S., Hellhammer D. H., Endocrine stress responses in TH1-mediated chronic inflammatory skin disease (psoriasis vulgaris)do they parallel stress-induced endocrine changes in TH2-mediated inflammatory dermatoses (atopic dermatitis)? Psychoneuroendocrinology 2006 31 4 439 446 2-s2.0-33644868488 10.1016/j.psyneuen.2005.10.006
108. Karanikas E., Harsoulis F., Giouzepas I., Griveas I., Chrisomallis F., Neuroendocrine stimulatory tests of hypothalamus-pituitary-adrenal axis in psoriasis and correlative implications with psychopathological and immune parameters. Journal of Dermatology 2009 36 1 35 44 2-s2.0-59549084823 10.1111/j.1346-8138.2008.00583.x
109. Harvima I. T., Viinamaki H., Naukkarinen A., Paukkonen K., Neittaanmaki H., Harvima R. J., Horsmanheimo M., Association of cutaneous mast cells and sensory nerves with psychic stress in psoriasis. Psychotherapy and Psychosomatics 1993 60 3-4 168 176 2-s2.0-0027360886
110. Locala J. A., Current concepts in psychodermatology. Current Psychiatry Reports 2009 11 3 211 218 2-s2.0-65749116769 10.1007/s11920-009-0033-x
111. Shenefelt P. D., Hypnosis in dermatology. Archives of Dermatology 2000 136 3 393 399 2-s2.0-0034014812
112. Shenefelt P. D., Biofeedback, cognitive-behavioral methods, and hypnosis in dermatology: is it all in your mind? Dermatologic Therapy 2003 16 2 114 122 2-s2.0-0042171759 10.1046/j.1529-8019.2003.01620.x
113. Heller M. M., Lee E. S., Koo J. Y., Stress as an influencing factor in psoriasis. Skin Therapy Letter 2011 16 5 1 4
114. Fortune D. G., Richards H. L., Griffiths C. E. M., Main C. J., Targeting cognitive-behaviour therapy to patient's implicit model of psoriasis: results from a patient preference controlled trial. British Journal of Clinical Psychology 2004 43 1 65 82 2-s2.0-1642367460 10.1348/014466504772812977